Calamos Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-25,380
Closed -$1.61M 924
2024
Q3
$1.61M Buy
25,380
+13,760
+118% +$871K 0.01% 608
2024
Q2
$616K Sell
11,620
-27,060
-70% -$1.43M ﹤0.01% 661
2024
Q1
$3.17M Buy
+38,680
New +$3.17M 0.02% 528